Morning Mr. D...
SHMN news. Any opinion?????
SOHM INC
Symbol U : SHMN
Recent Sedar Documents
SOHM, Inc. Announces Fourth Quarter and Fiscal Year 2011 Operating and Financial Results
2012-02-08 09:30 ET - News Release
BUENA PARK, CA -- (MARKET WIRE) -- 02/08/12
SOHM, Inc. (PINKSHEETS: SHMN), a generic pharmaceuticals, nutraceutical and dermatology company that manufactures and markets generic drugs covering all major treatment categories, today announced its financial result for 4th quarter and fiscal year 2011.
Revenues for the fourth quarter, period ending December 31, 2011 were $530,989, an increase of $391,726, or a 381% increase, as compared to the same period last year. Net loss for the quarter was $52,220, as compared to a net loss of $280,886 for the same period last year. The bottom line results improved 252% as compared to the same period last year.
Revenues for the full year 2011 were $1,349,341, an increase of $567,666, or a 72% increase as compared to 2010 revenues. Net loss for fiscal year 2011 was $548,990, as compared to a net loss of $980,457 for fiscal year 2010. The bottom line results for 2011 improved 44% as compared to fiscal year 2010.
Mr. Shailesh Shah, CEO of SOHM, Inc., stated, "We continue to make significant improvements in our top and bottom line results and believe our infrastructure, combined with our sales and marketing plans will continue to provide very good results. Last year we made strategic changes in our systems, including distribution channels and became very aggressive towards new product and new market launches, all of which provided our customers with better service and allowed us to streamline operations and control expenses."
"We are focusing our business plan on profitability by continuing to expand operations and partnerships, but ensuring that our expenses are in line with gross profit margins," concluded Mr. Shah.
AI
